Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma? (Q40905063)

24 September 2017

title

Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma? (English)

1 reference

24 September 2017

3

1 reference

24 September 2017

Sheng Han

1

1 reference

24 September 2017

Xiang Li

series ordinal

2

1 reference

24 September 2017

Tao Jiang

series ordinal

4

1 reference

24 September 2017

Anhua Wu

series ordinal

5

1 reference

24 September 2017

publication date

26 May 2015

1 reference

Journal of Neuro-Oncology

24 September 2017

published in

1 reference

24 September 2017

volume

124

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

45-55

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Relationship of glioblastoma multiforme to the subventricular zone is associated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Longitudinal MRI evidence for decreased survival among periventricular glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Expression of MHC I and NK ligands on human CD133 glioma cells: possible targets of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Persistence of CD133 cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Phosphorylated SATB1 is associated with the progression and prognosis of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Probabilistic radiographic atlas of glioblastoma phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Relationship of gliomas to the ventricular walls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-015-1818-X

Tumour-infiltrating CD4( ) and CD8( ) lymphocytes as predictors of clinical outcome in glioma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26007164

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26007164

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-015-1818-X

1 reference

Dimensions Publication ID

24 September 2017

1015360643

0 references

1 reference